PL2072056T3 - Sposób otrzymywania wysokowydajnej albuminy ludzkiej do stosowania w terapii detoksykacyjnej - Google Patents

Sposób otrzymywania wysokowydajnej albuminy ludzkiej do stosowania w terapii detoksykacyjnej

Info

Publication number
PL2072056T3
PL2072056T3 PL08380312T PL08380312T PL2072056T3 PL 2072056 T3 PL2072056 T3 PL 2072056T3 PL 08380312 T PL08380312 T PL 08380312T PL 08380312 T PL08380312 T PL 08380312T PL 2072056 T3 PL2072056 T3 PL 2072056T3
Authority
PL
Poland
Prior art keywords
high efficiency
obtaining high
human albumin
detoxification therapy
efficiency human
Prior art date
Application number
PL08380312T
Other languages
English (en)
Inventor
Nieto Juan Ignacio Jorquera
Debart Pere Ristol
Rierola Montserrat Costa
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39167937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2072056(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of PL2072056T3 publication Critical patent/PL2072056T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PL08380312T 2007-11-12 2008-11-06 Sposób otrzymywania wysokowydajnej albuminy ludzkiej do stosowania w terapii detoksykacyjnej PL2072056T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200702983A ES2294976B1 (es) 2007-11-12 2007-11-12 "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
EP08380312.2A EP2072056B1 (en) 2007-11-12 2008-11-06 Process for obtaining high efficiency human albumin for use in detoxification therapy

Publications (1)

Publication Number Publication Date
PL2072056T3 true PL2072056T3 (pl) 2016-06-30

Family

ID=39167937

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08380312T PL2072056T3 (pl) 2007-11-12 2008-11-06 Sposób otrzymywania wysokowydajnej albuminy ludzkiej do stosowania w terapii detoksykacyjnej

Country Status (16)

Country Link
US (2) US8088416B2 (pl)
EP (1) EP2072056B1 (pl)
JP (2) JP2009137947A (pl)
CN (1) CN101492493B (pl)
AR (1) AR069220A1 (pl)
AU (1) AU2008243225B2 (pl)
BR (1) BRPI0805167B8 (pl)
CA (1) CA2643508C (pl)
CL (1) CL2008003357A1 (pl)
ES (2) ES2294976B1 (pl)
HK (1) HK1129401A1 (pl)
HU (1) HUE026991T2 (pl)
MX (1) MX2008014273A (pl)
NZ (1) NZ572652A (pl)
PL (1) PL2072056T3 (pl)
RU (1) RU2424822C2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
CA2838964C (en) 2011-07-05 2021-07-13 Novozymes Biopharma Dk A/S Albumin formulation and use
WO2013125932A1 (ru) * 2012-02-22 2013-08-29 Даугавпилсский Университет Метод определения структурных и функциональных свойств альбумина плазмы крови
AU2013205138B2 (en) * 2012-08-09 2015-06-25 Grifols, S.A. Caprylate Viral Deactivation
CN103087184B (zh) * 2013-01-14 2014-04-02 山西康宝生物制品股份有限公司 人血白蛋白制品中激肽释放酶原激活剂的控制方法
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
ES2524516B1 (es) * 2014-05-29 2015-03-31 Grifols Worldwide Operations Limited Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido
KR102457855B1 (ko) 2016-08-17 2022-10-25 베링거 인겔하임 인터내셔날 게엠베하 생체 분자를 함유하는 고농축 액상 제형의 제조 방법
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5128727A (pl) 1974-09-04 1976-03-11 Canon Kk
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4749783A (en) * 1986-07-11 1988-06-07 Miles Laboratories, Inc. Viral inactivation and purification of active proteins
JP3554796B2 (ja) 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
FR2672604B1 (fr) 1991-02-07 1995-05-05 Pasteur Merieux Serums Vacc Procede pour isoler de l'albumine humaine a partir du surnageant iv, notamment iv-4, ou de la fraction v de cohn ou d'un surnageant ou fraction analogue.
US5368555A (en) * 1992-12-29 1994-11-29 Hepatix, Inc. Organ support system
AUPM388494A0 (en) * 1994-02-16 1994-03-10 Csl Limited Process for removing endotoxins
US5561115A (en) * 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
ES2107390B1 (es) 1996-01-30 1998-07-01 Grupo Grifolls S A Procedimiento para la preparacion de albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
ES2103236B1 (es) * 1996-01-30 1998-04-16 Grifols Grupo Sa Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
AT403989B (de) * 1996-09-16 1998-07-27 Immuno Ag Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
US6096872A (en) * 1997-10-14 2000-08-01 Ortho Diagnostic Systems, Inc. Viral clearance process
US5919907A (en) * 1997-12-22 1999-07-06 Shanbrom Technologies Llc Preparation and utilization of a novel sterile albumin
DE19831061A1 (de) * 1998-07-10 2000-01-13 Rotkreuzstiftung Zentrallab Herstellung von Proteinpräparationen mit verringertem Aggregatgehalt
ATE249847T1 (de) * 1999-06-15 2003-10-15 Bbi Bioseq Inc Schnelle tieftemperatur-drucksterilisation und impfstoffherstellung
CA2506848C (en) * 2002-11-25 2012-09-11 Octapharma Ag Prekallikrein depleted plasma derived albumin fraction
UA80469C2 (en) * 2003-02-13 2007-09-25 Octapharma Ag Method for the production of albumin
CN1756587A (zh) * 2003-03-12 2006-04-05 弗雷泽纽斯卡比德国有限公司 重组白蛋白在肝衰竭后透析中的用途
FR2866890B1 (fr) * 2004-02-27 2008-04-04 Lab Francais Du Fractionnement Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
WO2006066595A2 (en) * 2004-12-22 2006-06-29 Novozymes A/S Recombinant production of serum albumin
DE102005023155A1 (de) * 2005-05-13 2006-11-16 Albutec Gmbh Albuminlösung
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".

Also Published As

Publication number Publication date
JP2013173767A (ja) 2013-09-05
NZ572652A (en) 2010-03-26
AU2008243225A1 (en) 2009-05-28
ES2564310T3 (es) 2016-03-21
AU2008243225B2 (en) 2011-09-08
JP5744959B2 (ja) 2015-07-08
MX2008014273A (es) 2009-05-11
US8088416B2 (en) 2012-01-03
BRPI0805167B8 (pt) 2021-05-25
RU2008144318A (ru) 2010-05-20
US20090181102A1 (en) 2009-07-16
HK1129401A1 (en) 2009-11-27
EP2072056A1 (en) 2009-06-24
HUE026991T2 (en) 2016-08-29
CA2643508A1 (en) 2009-05-12
EP2072056B1 (en) 2016-02-24
BRPI0805167A2 (pt) 2009-07-14
ES2294976A1 (es) 2008-04-01
AR069220A1 (es) 2010-01-06
ES2294976B1 (es) 2008-12-16
CN101492493A (zh) 2009-07-29
CL2008003357A1 (es) 2011-01-07
US20110137283A1 (en) 2011-06-09
US8231599B2 (en) 2012-07-31
CN101492493B (zh) 2013-05-29
CA2643508C (en) 2013-06-11
JP2009137947A (ja) 2009-06-25
RU2424822C2 (ru) 2011-07-27
BRPI0805167B1 (pt) 2019-01-02

Similar Documents

Publication Publication Date Title
PL2072056T3 (pl) Sposób otrzymywania wysokowydajnej albuminy ludzkiej do stosowania w terapii detoksykacyjnej
EP2005806A4 (en) SETTING PATIENTS BY TOMOSYNTHESIS TECHNIQUES
ZA200903860B (en) Treatment of PRDC in pigs
EP2349421A4 (en) ENHANCING POWER MANAGEMENT IN A RESPIRATORY TREATMENT APPARATUS
ZA201000075B (en) Purin derivatives for use in the treatment of fab-related diseases
EP2444491B1 (en) Hyperglycosylated human coagulation factor IX
IL249838A0 (en) Telomerase activator compounds for use in the treatment of diseases related thereto
HK1153926A1 (en) Purin derivatives for use in the treatment of fab-related diseases fab-
GB0700436D0 (en) Impulse therapy for enhanced blood circulation in the body
EP2318031A4 (en) IMPROVED METHODS AND DEVICES FOR ANTIVIRAL THERAPY
GB2422552B (en) Heat therapy apparatus
HK1203160A1 (en) Tapentadol for the treatment of pain in arthrosis (tapentadol)
HUE037109T2 (hu) Endoxifén rák kezelésében történõ alkalmazásra
PL2422058T3 (pl) Wielostopniowo podgrzewany element o strukturze plastra miodu
IL205447A0 (en) Apparatus for creating therapeutic charge transfer in tissue
IL201944A0 (en) Method and system for combined energy therapy profile
GB0816650D0 (en) Therapeutic bone grwth and regeneration
HK1139671A1 (en) Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
GB0704982D0 (en) Improvements in or relating to photodynamic therapy
GB0509911D0 (en) Medical treatment aid for use in treating children
GB0516610D0 (en) Compounds for use in therapy
GB0819103D0 (en) Raphaine compounds and their use in therapy
GB2441116B (en) Improvements in and relating to medical apparatus
IL213399B (en) Hodah extraction for use in the treatment of liver diseases
GB0722751D0 (en) Use of gum arabic in therapy